[Place of ticlopidine in antiplatelet treatment].


Ticlopidine is an inhibitor of platelets function in vivo. It inhibits platelets aggregation induced by ADP. Its mode of action has not been defined, but it appears that metabolites of ticlopidine are antagonists of the platelet ADP receptor. Inhibition of platelet aggregation is delayed until 24 to 48 hours after drug administration, achieving maximum… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.